Zofran Birth Defect Lawsuits Discussed In New F.A.Q. Video Released By ZofranLegal.com

January 11, 2016 – – ZofranLegal.com reports on the release of a Zofran birth defect video which was developed to help individuals who are considering filing a lawsuit against anti-nausea drug Zofran and pharmaceutical manufacturer giant GlaxoSmithKline. ZofranLegal.com developed the online video designed to answer two of the most frequently asked questions that people most often have about pursuing their legal options. These questions include “How much does the process generally cost?” and “How does filing a lawsuit work?”

The informative video was released by the attorneys of Monheit Law, the firm who sponsors ZofranLegal.com, who have observed the unfortunate rise in Zofran-related birth defect lawsuits. These attorneys are currently working to help ensure that everyone who has been negatively affected by Zofran, but is not yet involved in the current lawsuits, will have the opportunity to look further into their legal rights.

Zofran lawsuits filed against GSK have been consolidated by the U.S. Judicial Panel on Multidistrict Litigation to form MDL number 2657 in Boston, Massachusetts. Today, they continue to grow in number and have been reported to number around 160. The plaintiffs involved in each lawsuit commonly allege that when growing fetuses in utero were exposed to Zofran through their mothers, it caused them to develop severe congenital birth defects.

The lawsuits reported by parents from across the nation vary in which birth defects they name. The defects most commonly mentioned, which were allegedly caused by Zofran exposure include kidney defects, cleft lip and palate, transposition of the greater vessels, tetralogy of fallot, atrial and ventricular septal defect, respiratory distress syndrome, and clubfoot. Some of the parents filing lawsuits against the anti-nausea drug manufacturer have lost children due to the fatal severity of the defects.

Mothers are generally prescribed Zofran to combat nausea episodes associated with morning sickness, despite the fact that the drug was never FDA-approved to treat them, or tested for safety on this consumer group. After Zofran gained FDA approval for cancer patients and patients undergoing anesthesia who were battling vomiting and nausea, GSK marketed the drug “off-label” to the public and OB/Gyn offices across the nation as a morning sickness treatment.

Morning sickness generally occurs during the first trimester of pregnancy, however, this is unfortunately also a time when the fetus does much of its initial heart, mouth, and limb tissue development. Parents claim that exposing the fetuses to the drug during this critical time of growth causes serious congenital defects to form.

Michael Monheit, Esq. of Monheit Law understands the devastation of these many parents, and is now working to ensure that anyone who used Zofran while pregnant and who later gave birth to a child with defects will have the important opportunity of exploring their legal rights. Through the release of these important videos, Monheit Law hopes to encourage those who are suffering to seek justice. The families and children involved may be entitled to legal action and compensation. At this time, Monheit Law is offering them free Zofran consultations.

To request additional information on Zofran lawsuits, or to ask questions, please contact Michael Monheit, Esq. by calling 877-620-8411.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60007133